Robust Denaturation of Villin Headpiece by MoS2 Nanosheet: Potential Molecular Origin of the Nanotoxicity
MoS 2 nanosheet, a new two-dimensional transition metal dichalcogenides nanomaterial, has attracted significant attentions lately due to many potential promising biomedical applications. Meanwhile, there is also a growing concern on its biocompatibility, with little known on its interactions with va...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2016-06, Vol.6 (1), p.28252-28252, Article 28252 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | MoS
2
nanosheet, a new two-dimensional transition metal dichalcogenides nanomaterial, has attracted significant attentions lately due to many potential promising biomedical applications. Meanwhile, there is also a growing concern on its biocompatibility, with little known on its interactions with various biomolecules such as proteins. In this study, we use all-atom molecular dynamics simulations to investigate the interaction of a MoS
2
nanosheet with Villin Headpiece (HP35), a model protein widely used in protein folding studies. We find that MoS
2
exhibits robust denaturing capability to HP35, with its secondary structures severely destroyed within hundreds of nanosecond simulations. Both aromatic and basic residues are critical for the protein anchoring onto MoS
2
surface, which then triggers the successive protein unfolding process. The main driving force behind the adsorption process is the dispersion interaction between protein and MoS
2
monolayer. Moreover, water molecules at the interface between some key hydrophobic residues (e.g. Trp-64) and MoS
2
surface also help to accelerate the process driven by nanoscale drying, which provides a strong hydrophobic force. These findings might have shed new light on the potential nanotoxicity of MoS
2
to proteins with atomic details, which should be helpful in guiding future biomedical applications of MoS
2
with its nanotoxicity mitigated. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/srep28252 |